Warren Sherman

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

Joshua M. Hare, Jay H. Traverse, Timothy D. Henry et al. · Journal of the American College of Cardiology · 2009 · 1.3K citations · Full text

Regenerative Medicine, Dose-escalation Study, Stem Cells +8

Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction

Simon Dixon, Thanh T. Nguyen, William W. O’Neill et al. · Journal of the American College of Cardiology · 2002 · 313 citations

Percutaneous Coronary Intervention, Cardiogenic Shock, Hyperthermia +8

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Jozef Bartúnek, André Terzic, Beth A. Davison et al. · European Heart Journal · 2016 · 180 citations · Full text

Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in Situ

Timothy P. Martens, Amandine F. G. Godier, Jonathan Parks et al. · Cell Transplantation · 2009 · 148 citations · Full text

Tissue Engineering, Catheter Delivery, Engineering +19

An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer et al. · Circulation Research · 2013 · 132 citations